In 2024, the medical technology sector experienced increased M&A activity, driven by a focus on growth and margin expansion. Companies prioritized early-stage acquisitions and strategic spin-offs while investing in disruptive technologies to strengthen their portfolios. Looking ahead to 2025, the industry is expected to sustain this momentum with increased M&A and IPO activity, supported by strong valuations and a wave of new product launches. Advancements in AI and robotics, coupled with a continued emphasis on remote patient monitoring, will drive continued growth.